CroiValve
@croivalve
Developing a safe, effective, minimally invasive and easy to deliver device for significantly reducing tricuspid regurgitation in high risk patients for surgery
ID: 854307292480774145
18-04-2017 12:15:05
63 Tweet
459 Followers
174 Following
Medtech start-up CroíValve raises €3.2m in record angel round siliconrepublic.com/start-ups/croi… via Silicon Republic
Tune in to the Best Innovations Session today at 13:00 CET where I present on behalf the Heart Team St James's Hospital our first-in-human experience of a novel tricuspid coaptation valve device CroiValve PCRonline 🫀 #PCRvalves Mark Hensey #tricuspid Andreas Rück Fadi Sawaya Salvatore Brugaletta
We are today delighted to launch University Bridge Fund II, an €80m Fund focused on scaling and commercialising extensively validated #research into the next generation of #deeptech companies with #globalpotential. European Investment Fund Enterprise Ireland AIB Trinity College Dublin University College Dublin UCC Ireland
Excellent #TVT2022 conference by Cardiovascular Research Foundation this week. Hugely informative discussions on the latest learnings on treating tricuspid regurgitation. And great to get such positive feedback in response our DUO technology.
👉Orthotopic valve therapies for tricuspid regurgitation in HCU #Valladolid - Pioneering for patients💪🏾 Thanks Sara Blasco Turrión for leading the tricuspid line and Tere SeRu, our 👀 Soc Esp Cardiología ACI-SEC: Hemodinamica Azeem Latib francesco maisano Maurizio taramasso Vinicius Esteves,MD PhD FESC CardioResis Valladolid Janar Sathananthan